Real-world data links once-monthly Uzedy to fewer ER visits, better adherence, and lower costs—plus fewer bipolar I relapses when switching from pills.
News|Videos|November 21, 2025
Southern Florida Psychiatry Conference: Welcome to Day 1!
Author(s)Ilan Melnick, MD
Welcome to Day 1 of So Flo Psychiatry!
Advertisement
CONFERENCE REPORTER
Ilan Melnick, MD, the program chair of the Southern Florida Psychiatry Conference, kicks off day 1 of this inaugural regional meeting in West Palm Beach, Florida. He is most excited to here the sessions on long-acting injectable agents in schizophrenia and managing postpartum depression.
Psychiatric Times will be on the ground covering sessions and providing exclusive interviews all weekend long. Check out all our conference coverage
Dr Melnick is the chief medical officer at Passageway Residence of Dade County in Miami, FL.
Advertisement
Related to this article
Experts highlight biomarker-driven schizophrenia care—computational subtypes, muscarinic drugs, sharper negative-symptom scoring, and KCC2 targets—reducing trial-and-error prescribing.
Panelists explain why precision tools lag in schizophrenia care and highlight simple biomarkers, faster deals, and clinician-industry collaboration.
Phase 3b data show centanafadine reduces adult ADHD and comorbid anxiety.
Advertisement
Advertisement
Trending on Psychiatric Times
1
The Psychiatric Pipeline in Review: Quarter 3, 2026
2
September 2026 in Review: Updates on the Psychiatric Treatment Pipeline, FDA News
3
Psychedelics as a Catalyst for Change: The Evolving Competitive Landscape in Depression
4
VA Expands Informed Consent Requirements for Psychotropic Medications Starting in 2027
5